Determination of whether the biological variation of fasting lipids differs between simvastatin and atorvastatin therapy in patients with type 2 diabetes: implications for treating to target

Completed

• Conditions: Type 2 diabetes, hypercholestrolemia; Nutritional, Metabolic, Endocrine

• Registration Number: ISRCTN73479504
• Lead Sponsor: Hull and East Yorkshire Hospitals NHS trust (UK)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2007-09-03
• Last Update Posted: 13 January 2015

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 20

Inclusion Criteria

Type 2 diabetes on either atorvastatin 10 mg or simvastatin 40 mg.

Exclusion Criteria

1. Not on concomitant fibrate or additional lipid lowering therapy
2. Inadequately treated hypothyroidism
3. Nephrotic syndrome

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Biological variability of TC and LDL-C (see Interventions for timepoints of measurement).

Secondary Outcome Measures

Name	Time	Method
Biological variation of triglycerides and hsCRP (see Interventions for timepoints of measurement).